[
  {
    "ts": null,
    "headline": "Cardinal Health Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
    "summary": "Cardinal Health Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=17b1c405d0606496d9a41e08f7cc75265dc6a91051738b430a411644ef6fd391",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746636960,
      "headline": "Cardinal Health Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
      "id": 134307895,
      "image": "",
      "related": "CAH",
      "source": "MarketWatch",
      "summary": "Cardinal Health Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=17b1c405d0606496d9a41e08f7cc75265dc6a91051738b430a411644ef6fd391"
    }
  },
  {
    "ts": null,
    "headline": "Charles River raises 2025 profit forecast, reaches deal with activist investor",
    "summary": "Charles River Laboratories shares jumped 15% on Wednesdayafter the company raised its annual profit forecast due to improving demand for contract drugresearch services. Separately, the...",
    "url": "https://finnhub.io/api/news?id=93a735686aaf661129cfe92360e504bc02db7d50bb5ebaaad992d868474b244b",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746619161,
      "headline": "Charles River raises 2025 profit forecast, reaches deal with activist investor",
      "id": 134296576,
      "image": "",
      "related": "CAH",
      "source": "Finnhub",
      "summary": "Charles River Laboratories shares jumped 15% on Wednesdayafter the company raised its annual profit forecast due to improving demand for contract drugresearch services. Separately, the...",
      "url": "https://finnhub.io/api/news?id=93a735686aaf661129cfe92360e504bc02db7d50bb5ebaaad992d868474b244b"
    }
  },
  {
    "ts": null,
    "headline": "2024 Total Dividend Income And Portfolio Update",
    "summary": "2024 also saw some changes to some of my holdings as the author shuttled several dividend income payers for higher return crypto plays. Click to read.",
    "url": "https://finnhub.io/api/news?id=e84a491388932db92b15edae67d11240e3b812c212aa814a6209bef6a4a9af74",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746617700,
      "headline": "2024 Total Dividend Income And Portfolio Update",
      "id": 134296532,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2007398242/image_2007398242.jpg?io=getty-c-w1536",
      "related": "CAH",
      "source": "SeekingAlpha",
      "summary": "2024 also saw some changes to some of my holdings as the author shuttled several dividend income payers for higher return crypto plays. Click to read.",
      "url": "https://finnhub.io/api/news?id=e84a491388932db92b15edae67d11240e3b812c212aa814a6209bef6a4a9af74"
    }
  },
  {
    "ts": null,
    "headline": "Cardinal Health releases new report on the cell and gene therapy industry",
    "summary": "Today, Cardinal Health (NYSE: CAH) released its 2025 Advanced Therapies Report: Revolutionizing patient care – the promise and potential of cell and gene therapies, providing insights into the evolving landscape of cell and gene therapies (CGTs).",
    "url": "https://finnhub.io/api/news?id=0a9c06e873fe5cfd6d81337556e53c3fc147adfa7cb66f9efdf14eba03b84327",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746617400,
      "headline": "Cardinal Health releases new report on the cell and gene therapy industry",
      "id": 134317278,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Today, Cardinal Health (NYSE: CAH) released its 2025 Advanced Therapies Report: Revolutionizing patient care – the promise and potential of cell and gene therapies, providing insights into the evolving landscape of cell and gene therapies (CGTs).",
      "url": "https://finnhub.io/api/news?id=0a9c06e873fe5cfd6d81337556e53c3fc147adfa7cb66f9efdf14eba03b84327"
    }
  },
  {
    "ts": null,
    "headline": "-Charles River agrees with Elliott to add new directors, review business",
    "summary": "Pharmaceutical companyCharles River Laboratories has reached a settlement withactivist investor Elliott Investment Management to add four newdirectors to its board and launch a strategic review of...",
    "url": "https://finnhub.io/api/news?id=0081cf3de5b9ef7b78e8c88a5e670322869b0b211d7c7b92756398f46b8e0c3a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746612730,
      "headline": "-Charles River agrees with Elliott to add new directors, review business",
      "id": 134295645,
      "image": "",
      "related": "CAH",
      "source": "Finnhub",
      "summary": "Pharmaceutical companyCharles River Laboratories has reached a settlement withactivist investor Elliott Investment Management to add four newdirectors to its board and launch a strategic review of...",
      "url": "https://finnhub.io/api/news?id=0081cf3de5b9ef7b78e8c88a5e670322869b0b211d7c7b92756398f46b8e0c3a"
    }
  },
  {
    "ts": null,
    "headline": "Charles River to add new directors, review business in agreement with Elliott",
    "summary": "Charles River Laboratoriessaid on Wednesday it had reached an agreement with activistinvestor Elliott Investment Management and added four newdirectors to its board, sending its shares up nearly...",
    "url": "https://finnhub.io/api/news?id=3626384eb06b5135f04735ddb91a78322f41b7ab5b8f576114283b025773f38f",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746606568,
      "headline": "Charles River to add new directors, review business in agreement with Elliott",
      "id": 134294632,
      "image": "",
      "related": "CAH",
      "source": "Finnhub",
      "summary": "Charles River Laboratoriessaid on Wednesday it had reached an agreement with activistinvestor Elliott Investment Management and added four newdirectors to its board, sending its shares up nearly...",
      "url": "https://finnhub.io/api/news?id=3626384eb06b5135f04735ddb91a78322f41b7ab5b8f576114283b025773f38f"
    }
  },
  {
    "ts": null,
    "headline": "Owens & Minor (OMI) Reports Q1: Everything You Need To Know Ahead Of Earnings",
    "summary": "Medical supply and logistics company Owens & Minor (NYSE:OMI) will be reporting earnings tomorrow before market hours. Here’s what to look for.",
    "url": "https://finnhub.io/api/news?id=3574b91069d43bed27d56dc0754f28858da55cce5f460fef81f195c1d438e18c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746601757,
      "headline": "Owens & Minor (OMI) Reports Q1: Everything You Need To Know Ahead Of Earnings",
      "id": 134291382,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Medical supply and logistics company Owens & Minor (NYSE:OMI) will be reporting earnings tomorrow before market hours. Here’s what to look for.",
      "url": "https://finnhub.io/api/news?id=3574b91069d43bed27d56dc0754f28858da55cce5f460fef81f195c1d438e18c"
    }
  },
  {
    "ts": null,
    "headline": "McKesson (MCK) To Report Earnings Tomorrow: Here Is What To Expect",
    "summary": "Healthcare distributor and services company McKesson (NYSE:MCK) will be reporting earnings tomorrow after market hours. Here’s what you need to know.",
    "url": "https://finnhub.io/api/news?id=d888fd0cc4896de8a96ebc84995e2e686d3203ec68d777279f936d13c0853a70",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746601655,
      "headline": "McKesson (MCK) To Report Earnings Tomorrow: Here Is What To Expect",
      "id": 134291323,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Healthcare distributor and services company McKesson (NYSE:MCK) will be reporting earnings tomorrow after market hours. Here’s what you need to know.",
      "url": "https://finnhub.io/api/news?id=d888fd0cc4896de8a96ebc84995e2e686d3203ec68d777279f936d13c0853a70"
    }
  },
  {
    "ts": null,
    "headline": "Exclusive-Charles River agrees with Elliott to add new directors, review business",
    "summary": "BEVERLY HILLS -Pharmaceutical company Charles River Laboratories has reached a settlement with activist investor Elliott Investment Management to add four new directors to its board and launch a...",
    "url": "https://finnhub.io/api/news?id=f0a0dc676defe915caef2d5197742700460883c360251533402cf12cd852bb5e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746597690,
      "headline": "Exclusive-Charles River agrees with Elliott to add new directors, review business",
      "id": 134291410,
      "image": "",
      "related": "CAH",
      "source": "Finnhub",
      "summary": "BEVERLY HILLS -Pharmaceutical company Charles River Laboratories has reached a settlement with activist investor Elliott Investment Management to add four new directors to its board and launch a...",
      "url": "https://finnhub.io/api/news?id=f0a0dc676defe915caef2d5197742700460883c360251533402cf12cd852bb5e"
    }
  },
  {
    "ts": null,
    "headline": "Charles River agrees with Elliott to add new directors, review business",
    "summary": "Pharmaceutical companyCharles River Laboratories has reached a settlement withactivist investor Elliott Investment Management to add four newdirectors to its board and launch a strategic review of...",
    "url": "https://finnhub.io/api/news?id=77dd9ef6bf3ad8d7aa3d19982827d49eecb7236e629622539d3fca1a5e614455",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746597690,
      "headline": "Charles River agrees with Elliott to add new directors, review business",
      "id": 134291241,
      "image": "",
      "related": "CAH",
      "source": "Finnhub",
      "summary": "Pharmaceutical companyCharles River Laboratories has reached a settlement withactivist investor Elliott Investment Management to add four newdirectors to its board and launch a strategic review of...",
      "url": "https://finnhub.io/api/news?id=77dd9ef6bf3ad8d7aa3d19982827d49eecb7236e629622539d3fca1a5e614455"
    }
  }
]